Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Absenteeism 1
- Abstracts 1
- Acinetobacter 1
- Adolescent 7
- Adult 12
- Aged 21
- Aged, 80 and over 12
- Aged, 80 And Over 1
- Ambulatory Care Facilities 1
- Animals 1
- Anthrax 3
- Anti-Bacterial Agents 1
- Anti-Infective Agents, Local 1
- Antibiotic stewardship 1
- Article 4
- Assisted Living Facilities 1
- Asymptomatic Diseases 3
- Bacillus Anthracis 1
- Bacillus anthracis 1
- Bacteremia 1
- Bacterial Infections 2
- Baths 1
- BetacoronaVirus 3
- Betacoronavirus 3
- Bioterrorism 3
- Camping 1
- Carbapenems 1
- Catheter-Related Infections 3
- Central Venous Catheters 1
- Cephalosporin Resistance 1
- Child 3
- Child, Preschool 2
- Chlorhexidine 1
- Chronic Disease 1
- Clinical Laboratory Techniques 4
- Clostridioides difficile 1
- Clostridioides difficile infection 1
- Clostridium Infections 1
- Cluster Analysis 1
- Cohort Studies 3
- Commerce 1
- Communicable Diseases, Emerging 1
- Communication 1
- Community-Acquired Infections 1
- Community-Acquired Infections/drug therapy 1
- Comorbidity 1
- CoronaVirus Infections 14
- Coronavirus Infections 5
- COVID-19 21
- COVID-19 Testing 2
- COVID-19 Vaccines 4
- COVID-19 Vaccines/Administration & Dosage 1
- COVID-19/Prevention & Control 1
- Cross Infection 8
- Disease Outbreaks 12
- Disease Transmission, Infectious 3
- Dispatch 2
- Drug Resistance, Multiple, Bacterial 2
- Environmental Monitoring 2
- Female 18
- Full Report 6
- Genome, Viral 2
- Health Facilities 2
- Health Personnel 2
- Hospitalization 5
- Hospital Mortality 3
- Hospitals 3
- Humans 33
- Immunization Schedule 2
- Incidence 4
- Infant 3
- Infection Control 5
- Inhalation Exposure 2
- Inpatients 2
- Intensive Care Units 2
- Length of Stay 2
- Long-Term Care 6
- Male 17
- Medicare 2
- Methicillin-Resistant Staphylococcus aureus 4
- Middle Aged 13
- Middle East Respiratory Syndrome Coronavirus 2
- Nursing Homes 5
- Original Article 2
- Pandemics 11
- Pneumonia, Viral 9
- Population Surveillance 2
- Respiratory Tract Infections 3
- Retrospective Studies 8
- Risk Assessment 2
- Risk Factors 5
- SARS-CoV-2 5
- Sepsis 3
- Severe Acute Respiratory Syndrome 2
- Skilled Nursing Facilities 9
- Staphylococcal Infections 2
- United States 8
- Vancomycin Resistance 2
- Washington 4
- Young Adult 7
Personal Author
Corporate Author
- Anthrax Bioterrorism Investigation Team 1
- Arkansas. Department of Health. 1
- CDC COVID-19 Emergency Response. 1
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Investigation Team. 3
- CDC COVID-19 Response Team. 3
- CDC Foundation. 1
- CDC Prevention Epicenters Program and the AHRQ DECIDE Network and Healthcare-Associated Infections Program 1
- Centers for Disease Control and Prevention (U.S.) 1
- Centers for Disease Control and Prevention (U.S.). Influenza Pandemic Framework Workgroup. 1
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. 2
- Connecticut Anthrax Investigation Team 1
- Connecticut Department of Public Health. 1
- Detroit (Mich.). Department of Health. 1
- Evergreen Health (Kirkland, WA) 1
- for the CDC Infection Prevention and Control Team and the CDC COVID-19 Surge Laboratory Group* 1
- for the CDC SARS Clinical Investigation Team 1
- King County (Wash.). Department of Community and Human Services. 1
- Lantana Consulting Group. 1
- Minnesota Long-Term Care COVID-19 Response Group 1
- National Center for Chronic Disease Prevention and Health Promotion (U.S.)Office on Smoking and Health. 1
- New Mexico. Department of Health. 1
- North Dakota. Department of Health. 1
- Public Health – Seattle & King County, EvergreenHealth, and CDC COVID-19 Investigation Team 1
- Public Health – Seattle & King County. 1
- Seattle-King County Department of Public Health. 2
- South Carolina. Department of Health and Environmental Control. 1
- Truth Initiative (Washington, DC) 1
- University of Washington. 1
- Utah. Department of Health. 1
- Vermont. Department of Health. 1
- Washington (State). Office of Public Health Laboratory. 1
- Washington State Department of Health. 1
- Washington State Department of Health.. 1
- Washington State Public Health Laboratory. 1
- Yale School of Public Health. 1
Place as Subject
- Africa, Western 1
- Arkansas 1
- Connecticut 3
- Detroit, MI 1
- Maryland 1
- Michigan 1
- Minnestota 1
- New Mexico 1
- North Dakota 1
- Saudi Arabia 2
- South Carolina 1
- United States 15
- Vermont 1
- Washington 7
Resource Type General
- Journal Article 50
- Journal Issue 1
- Report 1
Resource Type Specific
Keywords
- Adult 1
- Aged 3
- Aged, 80 and over 1
- Anti-Bacterial Agents 2
- Bacteremia 1
- bacteremia 1
- Baths 2
- Bifidobacterium 1
- Carrier State 1
- catheter-associated urinary tract infection 1
- Chlorhexidine 2
- chlorhexidine 1
- claims data 1
- Clostridioides difficile 1
- Community-Acquired Infections 1
- Comparative Effectiveness Research 1
- Cost-Benefit Analysis 1
- COVID-19 1
- Cross Infection 3
- Dietary supplement 1
- Disease Transmission, Infectious 1
- Disinfectants 1
- Disinfection 1
- Drug Resistance, Multiple, Bacterial 1
- elderly 1
- Enterococcus 1
- Enterocolitis, Pseudomembranous 1
- Female 2
- healthcare-associated infection 1
- health care costs 1
- hospital 1
- Hospitalization 1
- Hospitals 1
- Humans 5
- Infection Control 2
- Infections 1
- Intensive Care Units 2
- invasive bacterial disease 1
- Lactobacillus 1
- Male 2
- Markov Chains 1
- Medicare 1
- Medication Therapy Management 1
- Methicillin-Resistant Staphylococcus aureus 2
- methicillin resistance 1
- microbial 1
- Middle Aged 2
- mortality 1
- Mupirocin 1
- Nasal Cavity 2
- National Health Programs 1
- nonpharmaceutical intervention 1
- Pneumonia 1
- prevalence 1
- Probiotic 1
- regression analysis 1
- reimbursement 1
- Saccharomyces 1
- Safety Management 1
- Sepsis 1
- Staphylococcal Infections 2
- Staphylococcus aureus 1
- United States 3
- vancomycin resistance 1
Select all docs (Max 200)
1 -
20 of 52 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Absenteeism (1)
- Abstracts (1)
- Acinetobacter (1)
- Adolescent (7)
- Adult (12)
- Aged (21)
- Aged, 80 and over (12)
- Aged, 80 And Over (1)
- Ambulatory Care Facilities (1)
- Animals (1)
- Anthrax (3)
- Anti-Bacterial Agents (1)
- Anti-Infective Agents, Local (1)
- Antibiotic stewardship (1)
- Article (4)
- Assisted Living Facilities (1)
- Asymptomatic Diseases (3)
- Bacillus Anthracis (1)
- Bacillus anthracis (1)
- Bacteremia (1)
- Bacterial Infections (2)
- Baths (1)
- BetacoronaVirus (3)
- Betacoronavirus (3)
- Bioterrorism (3)
- Camping (1)
- Carbapenems (1)
- Catheter-Related Infections (3)
- Central Venous Catheters (1)
- Cephalosporin Resistance (1)
- Child (3)
- Child, Preschool (2)
- Chlorhexidine (1)
- Chronic Disease (1)
- Clinical Laboratory Techniques (4)
- Clostridioides difficile (1)
- Clostridioides difficile infection (1)
- Clostridium Infections (1)
- Cluster Analysis (1)
- Cohort Studies (3)
- Commerce (1)
- Communicable Diseases, Emerging (1)
- Communication (1)
- Community-Acquired Infections (1)
- Community-Acquired Infections/drug therapy (1)
- Comorbidity (1)
- CoronaVirus Infections (14)
- Coronavirus Infections (5)
- COVID-19 (21)
- COVID-19 Testing (2)
- COVID-19 Vaccines (4)
- COVID-19 Vaccines/Administration & Dosage (1)
- COVID-19/Prevention & Control (1)
- Cross Infection (8)
- Disease Outbreaks (12)
- Disease Transmission, Infectious (3)
- Dispatch (2)
- Drug Resistance, Multiple, Bacterial (2)
- Environmental Monitoring (2)
- Female (18)
- Full Report (6)
- Genome, Viral (2)
- Health Facilities (2)
- Health Personnel (2)
- Hospitalization (5)
- Hospital Mortality (3)
- Hospitals (3)
- Humans (33)
- Immunization Schedule (2)
- Incidence (4)
- Infant (3)
- Infection Control (5)
- Inhalation Exposure (2)
- Inpatients (2)
- Intensive Care Units (2)
- Length of Stay (2)
- Long-Term Care (6)
- Male (17)
- Medicare (2)
- Methicillin-Resistant Staphylococcus aureus (4)
- Middle Aged (13)
- Middle East Respiratory Syndrome Coronavirus (2)
- Nursing Homes (5)
- Original Article (2)
- Pandemics (11)
- Pneumonia, Viral (9)
- Population Surveillance (2)
- Respiratory Tract Infections (3)
- Retrospective Studies (8)
- Risk Assessment (2)
- Risk Factors (5)
- SARS-CoV-2 (5)
- Sepsis (3)
- Severe Acute Respiratory Syndrome (2)
- Skilled Nursing Facilities (9)
- Staphylococcal Infections (2)
- United States (8)
- Vancomycin Resistance (2)
- Washington (4)
- Young Adult (7)
- Anthrax Bioterrorism Investigation Team (1)
- Arkansas. Department of Health. (1)
- CDC COVID-19 Emergency Response. (1)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Investigation Team. (3)
- CDC COVID-19 Response Team. (3)
- CDC Foundation. (1)
- CDC Prevention Epicenters Program and the AHRQ DECIDE Network and Healthcare-Associated Infections Program (1)
- Centers for Disease Control and Prevention (U.S.) (1)
- Centers for Disease Control and Prevention (U.S.). Influenza Pandemic Framework Workgroup. (1)
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (2)
- Connecticut Anthrax Investigation Team (1)
- Connecticut Department of Public Health. (1)
- Detroit (Mich.). Department of Health. (1)
- Evergreen Health (Kirkland, WA) (1)
- for the CDC Infection Prevention and Control Team and the CDC COVID-19 Surge Laboratory Group* (1)
- for the CDC SARS Clinical Investigation Team (1)
- King County (Wash.). Department of Community and Human Services. (1)
- Lantana Consulting Group. (1)
- Minnesota Long-Term Care COVID-19 Response Group (1)
- National Center for Chronic Disease Prevention and Health Promotion (U.S.)Office on Smoking and Health. (1)
- New Mexico. Department of Health. (1)
- North Dakota. Department of Health. (1)
- Public Health – Seattle & King County, EvergreenHealth, and CDC COVID-19 Investigation Team (1)
- Public Health – Seattle & King County. (1)
- Seattle-King County Department of Public Health. (2)
- South Carolina. Department of Health and Environmental Control. (1)
- Truth Initiative (Washington, DC) (1)
- University of Washington. (1)
- Utah. Department of Health. (1)
- Vermont. Department of Health. (1)
- Washington (State). Office of Public Health Laboratory. (1)
- Washington State Department of Health. (1)
- Washington State Department of Health.. (1)
- Washington State Public Health Laboratory. (1)
- Yale School of Public Health. (1)
- Adult (1)
- Aged (3)
- Aged, 80 and over (1)
- Anti-Bacterial Agents (2)
- Bacteremia (1)
- bacteremia (1)
- Baths (2)
- Bifidobacterium (1)
- Carrier State (1)
- catheter-associated urinary tract infection (1)
- Chlorhexidine (2)
- chlorhexidine (1)
- claims data (1)
- Clostridioides difficile (1)
- Community-Acquired Infections (1)
- Comparative Effectiveness Research (1)
- Cost-Benefit Analysis (1)
- COVID-19 (1)
- Cross Infection (3)
- Dietary supplement (1)
- Disease Transmission, Infectious (1)
- Disinfectants (1)
- Disinfection (1)
- Drug Resistance, Multiple, Bacterial (1)
- elderly (1)
- Enterococcus (1)
- Enterocolitis, Pseudomembranous (1)
- Female (2)
- healthcare-associated infection (1)
- health care costs (1)
- hospital (1)
- Hospitalization (1)
- Hospitals (1)
- Humans (5)
- Infection Control (2)
- Infections (1)
- Intensive Care Units (2)
- invasive bacterial disease (1)
- Lactobacillus (1)
- Male (2)
- Markov Chains (1)
- Medicare (1)
- Medication Therapy Management (1)
- Methicillin-Resistant Staphylococcus aureus (2)
- methicillin resistance (1)
- microbial (1)
- Middle Aged (2)
- mortality (1)
- Mupirocin (1)
- Nasal Cavity (2)
- National Health Programs (1)
- nonpharmaceutical intervention (1)
- Pneumonia (1)
- prevalence (1)
- Probiotic (1)
- regression analysis (1)
- reimbursement (1)
- Saccharomyces (1)
- Safety Management (1)
- Sepsis (1)
- Staphylococcal Infections (2)
- Staphylococcus aureus (1)
- United States (3)
- vancomycin resistance (1)
- :Wise, Matthew E. ;Scott, R. DouglasApr 18 2013 | Infect Control Hosp Epidemiol. 34(6):547-554.:OBJECTIVERecent studies have demonstrated that central line–associated bloodstream infections (CLABSIs) are preventable through implementation of ev...
- :Gorwitz, Rachel J. ;Jernigan, Daniel B.March 2006:Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a cause of skin infections and, less commonly, invasive infections among otherwise h...
- :Yi, Sarah H. ;Hatfield, Kelly M.Apr 17 2018 | Clin Infect Dis. 66(9):1333-1341:Background.Previous studies suggest that duration of antibiotic therapy for community-acquired pneumonia (CAP) often exceeds national recommendations ...
- :Kazakova, Sophia ;Baggs, JamesOct 04 2017 | Open Forum Infect Dis. 2017; 4(Suppl 1):S1.:BackgroundThis study investigated the association between facility-level rates of hospital-onset CDI (HO-CDI) and inpatient antibiotic use (AU) in a l...
- :Scott, R. Douglas ;Slayton, Rachel B.Jan 22 2019 | Antimicrob Resist Infect Control. 8:BackgoundEconomic evaluations of interventions to prevent healthcare-associated infections in the United States rarely take the societal perspective a...
- :Hastings, Deborah L. ;Tokars, Jerome I.May 2016 | Emerg Infect Dis. 22(5):794-801.:During March-May 2014, a Middle East respiratory syndrome (MERS) outbreak occurred in Jeddah, Saudi Arabia, that included many persons who worked or r...
- :Alraddadi, Basem M. ;Al-Salmi, Hanadi S.Nov 2016 | Emerg Infect Dis. 22(11):1915-1920.:Healthcare settings can amplify transmission of Middle East respiratory syndrome coronavirus (MERS-CoV), but knowledge gaps about the epidemiology of ...
- :Jernigan, John A. ;Low, Donald E.Feb 2004 | Emerg Infect Dis. 10(2):327-333.:Early recognition and rapid initiation of infection control precautions are currently the most important strategies for controlling severe acute respi...
- :McMichael, Temet M. ;Currie, Dustin W.3 27 2020 | N Engl J Med. 2020;:BackgroundLong-term care facilities are high-risk settings for severe outcomes from outbreaks of Covid-19, owing to both the advanced age and frequent...
- :Arons, Melissa M. ;Hatfield, Kelly M.4 24 2020 | N Engl J Med. 2020;:BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can spread rapidly within skilled nursing facilities. After identific...
- :McKay, Susannah L. ;Tobolowsky, Farrell A.Apr 27 2021 | Ann Intern Med. 2021;:Background:To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. How...
- :Slayton, Rachel B. ;Scott, R. Douglas6 2015 | Infect Control Hosp Epidemiol. 36(6):681-687:OBJECTIVE.To determine the potential epidemiologic and economic value of the implementation of a multifaceted Clostridium difficile infection (CDI) co...
- :Jernigan, John A. ;McDonald, L. Clifford7 02 2020 | N Engl J Med. 383(1):94
- :Khong, Carolyn ;Baggs, James8 2015 | Infect Control Hosp Epidemiol. 36(8):886-892:ObjectiveWe sought to determine whether central line-associated bloodstream infections (CLABSI) increase the likelihood of readmission.DesignRetrospec...
- :Jernigan, John A. ;Hatfield, Kelly M.4 02 2020 | N Engl J Med. 382(14):1309-1319:BACKGROUNDMultidrug-resistant (MDR) bacteria that are commonly associated with health care cause a substantial health burden. Updated national estimat...
- :Hatfield, Kelly M. ;Reddy, Sujan C.7 09 2020 | N Engl J Med. 383(2):192
- :Huang, Susan S. ;Septimus, Edward6 13 2013 | N Engl J Med. 368(24):2255-2265:BACKGROUNDBoth targeted decolonization and universal decolonization of patients in intensive care units (ICUs) are candidate strategies to prevent hea...
- :Septimus, Edward J. ;Hayden, Mary K.10 2014 | Infect Control Hosp Epidemiol. 35(Suppl 3):S17-S22:OBJECTIVE.To determine rates of blood culture contamination comparing 3 strategies to prevent intensive care unit (ICU) infections: screening and isol...
- :Rhee, Chanu ;Jentzsch, Maximilian S.April 2019 | Crit Care Med. 47(4):493-500:Objectives:Administrative claims data are commonly used for sepsis surveillance, research, and quality improvement. However, variations in diagnosis, ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.